The global glucose monitoring devices market to reach $13.7 billion by 2019, reveals new report

The global glucose monitoring devices market value will experience a moderate increase from $9.9 billion in 2012 to $13.7 billion by 2019, at a Compound Annual Growth Rate (CAGR) of 5%, forecasts business intelligence report.

According to the latest “Glucose Monitoring Device Market to 2019 - Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivers” report, emerging countries, such as China and India, show the most potential for market growth, as they have the largest diabetic populations consisting of 92 million and 63 million people, respectively.

In fact, the Asia-Pacific market for glucose monitoring is expected to double from $1.5 billion in 2012 to $3 billion by 2019, at a CAGR of 10%. Still, the US and Europe will continue to lead this setting by 2019, with shares of 34% and 40%, respectively.

Inquiry for more information visit:  http://www.marketresearchreports.com/gbi-research/glucose-monitoring-device-market-2019-technology-adoption-and-increasing-health

Leading analyst covering this report says: “Rapid urbanization and changes in lifestyle habits have made people in developing countries especially vulnerable to disorders such as diabetes. However, poor healthcare infrastructure, urban-rural disparity and a lack of skilled healthcare professionals have previously limited the adoption and use of devices for the prevention and treatment of diabetes in these markets.”

Publisher now expects the increasing awareness of the importance of glucose monitoring, along with technical innovations minimizing the blood required for glucose testing, to drive the adoption of such devices in the Asia-Pacific region during the forecast period.

Analyst says: “One of the key technological developments in the diabetes care industry is Continuous Glucose Monitoring (CGM), which helps patients to measure glucose levels regularly, unlike traditional devices. CGM devices are programmed to alert users to low or high glucose levels, allowing for timely medication and reducing any risk of associated complications due to undesired changes in glycemic levels.”

With diabetes becoming an increasingly major burden globally, GBI Research believes that early detection through regular monitoring can improve the control and treatment of the disease.

This report provides information on market size for the three glucose monitoring devices market segments: blood glucose meters, blood glucose testing strips, and lancets. Countries covered include the US, Canada, Germany, France, Italy, Spain, the UK, Japan, China, India, Australia and Brazil.

Spanning over 90 pages, 55 Tables and 54 Figures “Glucose Monitoring Device Market to 2019 - Technology Adoption and Increasing Health Awareness Serve as Distinct Regional Growth Drivers” report provide Introduction, Global Glucose Monitoring Device Market: Device Overview, Global Glucose Monitoring Device Market: Market Characterization, Segment Analysis and Forecasts, Country Analysis and Forecasts, Reimbursement System, Competitive Landscape,  Product Pipeline Analysis, Consolidation Landscape. The report covers 5 companies - F. Hoffmann-La Roche Ltd., LifeScan, Bayer Healthcare AG, Abbott Laboratories and Arkay, Inc.

Find All Pharma & Healthcare Technology Reports at: http://www.marketresearchreports.com/pharma-healthcare-technology

For regular industry updates subscribe to our newsletter at: http://www.marketresearchreports.com/subscribe-to-newsletter